The Federal Bureau of Investigation’s website is a valuable resource. It has a lot of information about many different types of identity theft that we at ProtectMyID want to share with our readers. Once a month, we highlight a news announcement, article, alert, or other item from the FBI website about identity theft so you can learn more about how the crime is perpetrated.
ORLANDO, FL—United States Attorney Robert E. O’Neill announces the unsealing of a 15-count indictment charging Allen Gregory Schleicher, a/k/a Gregory Klonowski, (49, Ruskin) with 10 counts of mail fraud, four counts of money laundering, and one count of aggravated identity theft. If convicted, Schleicher faces a maximum penalty of 20 years in federal prison for each mail fraud charge, 10 years in federal prison for each money laundering charge, and two years in federal prison, consecutive to any other sentence, for the aggravated identity theft charge. The indictment also notifies Schleicher that the United States intends to forfeit the real property located at 1829 Raven Glen Drive, Ruskin, Florida, which is alleged to be traceable to proceeds of the offenses.
According to the indictment, in September 2000, Schleicher fraudulently obtained a pharmacist license from the Florida Department of Health by using the name, date of birth, Social Security number and pharmacy education of another individual (hereinafter referred to as “A.R.S.”). Between September 2000 and July 2009, Schleicher worked as a pharmacist in Central Florida. During that time, Schleicher submitted periodic renewals of the pharmacist license belonging to “A.R.S.” and received paychecks through the mail. Schleicher allegedly used the proceeds of his fraudulent conduct to purchase the property located at 1829 Raven Glen Drive, Ruskin, Florida.
An indictment is merely a formal charge that a defendant has committed a violation of the federal criminal laws, and every defendant is presumed innocent unless and until proven guilty.
This case was investigated by the Federal Bureau of Investigation and the Drug Enforcement Administration with the assistance of the Florida Department of Health’s Division of Medical Quality Assurance. It will be prosecuted by Assistant United States Attorney David Haas.